Treatment of the cells with MG132 led to an increase in the protein levels of Rap1GAP in the HPV-positive cervical cancer cells, HeLa and SiHa, but not in the HPV-negative cervical cancer cell line, C33A (Fig. 1). The gene discussed is RAP1GAP; the disease is cervical cancer.